๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A placebo-controlled pilot discontinuation trial following haloperidol treatment of behavioral and psychotic symptoms in Alzheimer's disease

โœ Scribed by Devanand, Davangere P.; Pelton, Gregory H.

Book ID
121934561
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
40 KB
Volume
6
Category
Article
ISSN
1552-5260

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A 6-month, randomized, double-blind, pla
A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease
โœ D.P. Devanand; Gregory H. Pelton; Karine Cunqueiro; Harold A. Sackeim; Karen Mar ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 215 KB ๐Ÿ‘ 2 views

## Abstract ## Objective In patients with Alzheimer's disease (AD) with psychosis or agitation that respond to haloperidol treatment, to evaluate the risk of relapse following discontinuation. ## Methods In outpatients with AD with symptoms of psychosis or agitation, responders to 20 weeks of ha

A pilot placebo-controlled study of traz
A pilot placebo-controlled study of trazodone and buspirone in alzheimer's disease
โœ Dr. Brian A. Lawlor; Jeanne Radcliffe; Susan E. Molchan; Rick A. Martinez; James ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 506 KB

The pharmacological management of behavioural symptoms in Alzheimer's disease is limited by the dearth of effective agents in this area. The purpose of this study was to determine whether trazodone or buspirone are helpful in the treatment of behavioural disturbance in AD. Ten patients meeting NINCD